Pharmacokinetics of a new human plasma‐derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients-Reference-Cited by-同舟云学术

Pharmacokinetics of a new human plasma‐derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients

Published:2019-09-11 Issue:6 Volume:25 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Castaman Giancarlo¹,Borchiellini Alessandra²,Santagostino Elena³,Tagariello Giuseppe⁴^ORCID,Serban Margit⁵,Uscatescu Marusia⁶,Truica Cristina⁷,Farrugia Albert⁸^ORCID,Morfini Massimo⁹^ORCID

Affiliation:

1. AOU Careggi Malattie Emorragiche e della Coagulazione Firenze Italy

2. Department of Haematology S. Giovanni Battista Hospital Turin Italy

3. Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Foundation Maggiore Hospital Policlinico Milan Italy

4. Department of Haematology Haemophilia Centre Castelfranco Veneto Italy

5. Louis Turcanu' Louis Turcanu” Children Clinical Emergency Hospital Timisoara Romania

6. Fundeni Clinical Institute Bucharest Romania

7. Hematology Department Country Emergency Hospital Baia Mare Romania

8. Surgery (QEII Medical Centre) The University of Western Australia (M509) Crawley WA Australia

9. Italian Association of Haemophilia Centres Milan Italy

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13828

Reference10 articles.

1. Neoantigens and antibodies to factor VIII

2. Committee for Proprietary Medicinal Products (Cpmp).Guideline on plasma‐derived medicinal products. July 21 2011 pag.11/33.https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-plasma-derived-medicinal-products_en.pdf. Accessed on May 29 2019.

3. The Design and Analysis of Half-Life and Recovery Studies for Factor VIII and Factor IX

4. LeeM MorfiniM SchulmanS Ingerslev J the Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis.Scientific and standardization committee communication: the design and analysis of pharmacokinetic studies of coagulation factors. ISTH Web site. Accessed March 21 2001:1‐9.

5. In vivo recovery of factor VIII following transfusion: a survey of recent data and publications to assess the influence of standards used for potency assignment. On behalf of the Subcommittee on Factor VIII and IX of the Scientific and Standardization Committee of the ISTH;Prowse CV;Thromb Haemost,1995

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic characteristics of the triple inactivated plasma-derived Kedrion FIX concentrate: data from the KB037 clinical trial;Data in Brief;2020-10

2. Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate;European Journal of Pharmaceutical Sciences;2020-10